Skip to main content

This translation is provided for general access and has no recorded medical-language review.

General medical information

Information on Mesotherapy

This page provides only a general scope and sources for Information on Mesotherapy. Personal suitability, the product or device used, potential benefit, risks, alternatives and the option of no procedure require a physician examination.

Direct answer

  • Mesotherapy is not one product or a standard treatment but a general name for methods that inject different substances into the skin.
  • The name, purpose, product information, evidence and risks of the intended substance should each be verified before the procedure.

Scope of this page

Online content is not diagnosis, prescribing, personal risk assessment or a treatment plan. A reference list is not a clinical sign-off; product and device information must also be checked against current Turkish registration and instructions for use.

Sources and evidence scope

These sources are editorial starting points. Each may be limited to a specific product, method, indication or study population.

Source titles remain in their publication language. Localized notes summarize the interpretation boundary and do not replace the full text. This translation has no recorded clinical or medical-language review.

  1. International Consensus Guidelines on the Safe and Evidence-Based Practice of Mesotherapy: A Multidisciplinary Statement

    Massimo Mammucari, Domenico Russo, Enrica Maggiori, Marco Rossi, Marzia Lugli, Raffaele Di Marzo, Alberto Migliore, Raimondo Leone, Kamil Koszela, Giustino Varrassi; International Expert Panel · 2025 · Clinical consensus guideline

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local product or device information.

    Editorial source — not a clinical sign-off record

  2. Efficacy and Safety of Amino Acid-Enriched Hyaluronic Acid in Facial Rejuvenation: A Systematic Review and Meta-Analysis

    Maite Mosteirin, Ava Guila Ardila, Raul Gil Calomarde, Gonzalo Mariscal · 2026 · Systematic review and meta-analysis

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local product or device information.

    Editorial source — not a clinical sign-off record

  3. Injectable Therapy for Androgenetic Alopecia: A Systematic Review

    Jacob Beer, Tanya Boghosian, Hannah Mendez, Mira Sayegh, Nazar Boghosian, Antonella Tosti · 2026 · Systematic review

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local product or device information.

    Editorial source — not a clinical sign-off record

Source-backed general information

5

Mesotherapy for hair loss: why ask about the substance and limits of evidence?

Mesotherapy is not one medicine, substance or standard protocol. After diagnosis, ask which agent is being considered, for what purpose and on what evidence.

Why is content transparency necessary in mesotherapy?

“Vitamin cocktail” or “rejuvenation mix” is not a product name; each component's identity, authorisation, injection purpose and risk are separate. One label may cover different devices, needle depths, energy, contents and protocols; studies cannot be treated as directly equivalent.

Are products called skin boosters equivalent?

Skin booster is a marketing label that may cover different hyaluronic-acid structures, amino acids or other contents; evidence and authorisation vary by product. Skin procedures vary in contents, depth, energy, sterility and protocol; one general label does not establish equivalence.

Why are allergy and anaphylaxis preparedness reviewed beforehand?

Products, antiseptics, latex, adhesives or anaesthetics can cause different reactions; details of a previous event change risk planning. General information must be interpreted with personal history, examination, current product or device documentation, local regulation and follow-up capacity.

Are topical exosomes, application after microneedling and injection equivalent?

Topical application, use over a disrupted barrier and injection are different exposure routes with different absorption, sterility requirements and potential risks. A small study using one route does not establish safety or effectiveness for another.